 direct effect hyperinsulinemia serum sex hormone-binding globulin levels obese women polycystic ovary syndrome hyperinsulinemia sex hormone-binding globulin SHBG levels obese women polycystic ovary syndrome obese women disorder study ovarian steroid production woman administration mg long-acting GnRH agonist leuprolide depot im days substantial reductions serum concentrations testosterone nmol/L day nmol/L day non-SHBG-bound testosterone pmol/L day pmol/L day nmol/L day nmol/L day pmol/L day pmol/L day pmol/L day pmol/L day progesterone nmol/L day nmol/L day Serum SHBG levels change nmol/L day nmol/L day leuprolide treatment women oral diazoxide mg/day days serum insulin levels Diazoxide treatment suppressed insulin release oral glucose tolerance test insulin area curve nmol/min.L day nmol/min.L day deterioration glucose tolerance Serum testosterone androstenedione estrone estradiol progesterone levels combined diazoxide leuprolide treatment contrast SHBG levels nmol/L day nmol/L day Due rise serum SHBG levels non-SHBG-bound testosterone levels pmol/L day pmol/L day observations hyperinsulinemia serum SHBG levels obese women polycystic ovary syndrome effect serum sex steroids